Firefly Neuroscience Accepted into NVIDIA Connect Program
KENMORE, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) — Firefly Neuroscience, Inc. (“Firefly,” or the “Company”) (NASDAQ: AIFF), a pioneering Artificial Intelligence (“AI”) company committed to advancing brain health solutions, has proudly announced its acceptance into the highly esteemed NVIDIA Connect program. This strategic achievement offers Firefly access to powerful tools and resources that are critical in their quest to develop a groundbreaking proprietary foundation model of the human brain.
Firefly Neuroscience is renowned for its dedicated efforts in enhancing brain health for patients suffering from various neurological and mental disorders. The company leverages its FDA-cleared Brain Network Analytics (“BNA”) technology platform, which optimally utilizes Resting EEG and Cognitive EEG (ERP) data, to push the boundaries of innovation in this field.
The NVIDIA Connect program is a celebrated initiative that provides access to NVIDIA’s leading-edge software development tools, industry-standard frameworks, and software development kits. It also integrates a comprehensive global ecosystem designed to accelerate growth for member companies. Benefits of the program include robust technical training, expert engineering guidance, and valuable discounts on NVIDIA software and hardware. These advantages are pivotal in expediting development processes and enhancing operational efficiency.
“We are honored and excited to be among the select few medtech companies—big, medium, or small—to be accepted into the prestigious NVIDIA Connect program,” expressed Greg Lipschitz, Executive Chairman of Firefly. His statement underscores the significance of this accomplishment for Firefly at such a pivotal moment in their journey.
Mr. Lipschitz further elaborated, “This marks the achievement of an important milestone for Firefly and comes at an extremely opportune time. Our already unparalleled BNA database continues to expand with each new clinical study and assessment where our technology is utilized. With privileged access to the best NVIDIA hardware and cutting-edge resources, we believe Firefly is now uniquely positioned to construct the world’s first foundation model of the human brain.”
Firefly’s entry into this program signifies a commitment to making notable contributions to neuroscience and related AI sectors. The initiative not only opens new avenues for technological advancement but also promises significant enhancements in clinical applications, which could benefit researchers, clinicians, and patients alike. The transition into this phase of development will be closely monitored by the company’s stakeholders, including investors, who are eager to witness the impact of these innovations.
As the company embarks on this transformative journey, updates will be provided to all stakeholders, ensuring transparency and engagement from the ground up. The collaboration with NVIDIA not only enhances Firefly’s ability to innovate but also aligns with their mission to revolutionize the way brain health issues are understood and treated.
By leveraging the power of NVIDIA’s platform, Firefly envisages the development of AI-driven solutions that have the potential to redefine neurological and mental disorder assessments and treatments. The future looks promising as Firefly Neuroscience merges its visionary approach with NVIDIA’s technological prowess.
This strategic partnership is poised to contribute significantly to the fields of neuroscience, AI, and medical technology, paving the way for new insights and breakthroughs in understanding the intricacies of the human brain.
